Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-08-15 Option Award | 2023-08-18 7:07 pm | N/A N/A | BioSig Technologies Inc. | BSGM | Weild IV David Director | 16,000 | $0 | 114,999 (Direct) | View |
2023-04-20 Option Award | 2023-04-21 4:33 pm | N/A N/A | BioSig Technologies Inc. | BSGM | Weild IV David Director | 17,544 | $0 | 98,999 (Direct) | View |
2023-02-24 Option Award | 2023-02-28 6:44 pm | N/A N/A | BioSig Technologies Inc. | BSGM | Weild IV David Director | 16,000 | $0 | 81,455 (Direct) | View |
2022-11-18 Option Award | 2022-11-22 8:08 pm | N/A N/A | BioSig Technologies Inc. | BSGM | Weild IV David Director | 45,455 | $0 | 65,455 (Direct) | View |
2021-12-28 Option Award | 2022-04-25 5:20 pm | N/A 2031-12-28 | BioSig Technologies Inc. | BSGM | Weild IV David Director | 75,000 | $0 | 75,000 (Direct) | View |
2021-04-01 Option Award | 2021-04-05 6:18 pm | N/A 2031-04-01 | PAVmed Inc. | PAVM | Weild IV David Director | 50,000 | $0 | 50,000 (Direct) | View |
Ownership | 2020-12-28 7:44 pm | 2021-03-31 2025-12-15 | Scopus BioPharma Inc. | SCPS | Weild IV David Director | 0 | $0 | 100,000 (Direct) | View |
2020-04-30 Option Award | 2020-05-04 6:08 pm | N/A 2030-04-30 | PAVmed Inc. | PAVM | Weild IV David Director | 100,000 | $0 | 100,000 (Direct) | View |
2020-04-14 Option Award | 2020-04-16 11:48 am | N/A 2030-04-14 | BioSig Technologies Inc. | BSGM | Weild IV David Director | 75,000 | $0 | 75,000 (Direct) | View |